Shal'nev V I
Ter Arkh. 1996;68(5):55-6.
36 patients with macrofocal myocardial infarction (MI) underwent systemic thrombolytic therapy with avelysin (500,000-750,000 U) within the disease first 6 hours. By the results of the treatment 2 groups were identified: patients with thrombolysis and myocardial reperfusion (n = 20), patients free of reperfusion manifestations (n = 16). The patients were examined in hospital and outside 10 months after MI development: myocardial contractility and hemodynamics were assessed at echocardiography and radiocardiography, exercise tolerance, coronary and myocardial cardiac reserves using bicycle ergometry. Better exercise tolerance and myocardial contractility were shown both in hospital and in follow-up by patients with myocardial reperfusion. According to the follow-up findings, myocardial contractility was such the same as that on postinfarction week 4, exercise tolerance was much higher than at the first examination. Thus, myocardial reperfusion affects positively the parameters studied in MI patients.
36例大面积心肌梗死患者在发病后6小时内接受了阿韦利辛(500,000 - 750,000单位)的全身溶栓治疗。根据治疗结果,分为两组:溶栓及心肌再灌注患者(n = 20),无再灌注表现患者(n = 16)。患者在心肌梗死发生后10个月内在医院及院外接受检查:通过超声心动图和放射性心动图评估心肌收缩力和血流动力学,使用自行车测力计评估运动耐量、冠状动脉和心肌储备。心肌再灌注患者在住院期间和随访中均表现出更好的运动耐量和心肌收缩力。根据随访结果,心肌收缩力与梗死后第4周相同,运动耐量远高于首次检查时。因此,心肌再灌注对心肌梗死患者的研究参数有积极影响。